RESMED INC — Director's Dealing 2017

Jul 17, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2017-07-14

Reporting Person: Hollingshead James (President, Americas)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-07-14	ResMed Common Stock	M	5265	$43.63	Acquired	43358	Direct
2017-07-14	ResMed Common Stock	S	5265	$77.43	Disposed	38093	Direct
2017-07-14	ResMed Common Stock	S	1875	$77.43	Disposed	36218	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-07-14	ResMed Common Stock Options	$43.63	M	5265	Disposed	2020-03-01	ResMed Common Stock (5265)	Direct

Footnotes

F1: The transaction was conducted under a Rule 10b5-1 Plan.

F2: Includes 298 shares of ResMed stock purchased on April 28, 2017, through the ResMed Employee Stock Purchase Plan.

F3: Represents date options first became exercisable. Options vest ? per year.